Who invested in Myelo Therapeutics?
Myelo Therapeutics's investors include European Commission and IBB Ventures.
Germany · Funded startup
Funding summaryUpdated 26 Oct 2026
$17Mraised across 1 round since 2022, from 1 source
Myelo Therapeutics's investors include European Commission and IBB Ventures.
Myelo Therapeutics has raised $17M across 1 round since 2022.
Myelo Therapeutics's most recent round was a Grant of $17M in Aug 2022.
Its most recent round, $17M in Aug 2022, is also its largest on record.
Myelo Therapeutics's first round on record, in Aug 2022, was backed by European Commission and IBB Ventures.
Myelo Therapeutics's latest named round is a Grant, in Aug 2022.
Myelo Therapeutics is based in Germany.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.